Puma Biotechnology (PBYI) Stock Chart & Stock Price History → Nvidia is Pivoting to Solve Big Tech’s $1 Trillion Problem (From Weiss Ratings) (Ad) Free PBYI Stock Alerts $3.85 +0.04 (+1.05%) (As of 05/31/2024 08:51 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Puma Biotechnology Stock Price Performance5 Day Performance-0.77%1 Month Performance-20.78%3 Month Performance-34.63%6 Month Performance+2.67%Year-To-Date Performance-11.09%1 Year Performance+8.45% Receive PBYI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Puma Biotechnology and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Timothy SykesBill Gates is all about this tiny $2 stockWhat does Bill Gates know about this tiny company that we don’t? From the outside, it looks like a worthless $2 stock…>>Click here to discover why Bill Gates is all about this tiny $2 stock. PBYI Stock Chart for Monday, June, 3, 2024 PBYI Chart by TradingView Puma Biotechnology Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$3.81$3.85+1.05%$3.94$3.75208,920 shs$185.72 million05/30/2024$3.88$3.81-1.80%$4.08$3.78280,903 shs$183.79 million05/29/2024$4.02$3.88-3.48%$4.04$3.88206,406 shs$187.17 million05/28/2024$4.00$4.02+0.50%$4.09$3.93292,512 shs$193.92 million05/27/2024$4.00$4.00$4.03$3.88239,900 shs$192.96 million05/24/2024$3.99$4.00+0.25%$4.03$3.88239,984 shs$192.96 million Get the Latest News and Ratings for PBYI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Puma Biotechnology and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024$4.23$3.99-5.67%$4.23$3.92407,142 shs$192.47 million05/22/2024$4.17$4.23+1.44%$4.44$4.07271,557 shs$204.06 million05/21/2024$4.37$4.17-4.58%$4.44$4.12288,982 shs$201.16 million05/20/2024$4.10$4.37+6.72%$4.82$4.101.62 million shs$210.81 million05/17/2024$4.41$4.10-7.14%$4.97$4.081.52 million shs$197.54 million05/16/2024$4.65$4.41-5.16%$4.68$4.38290,391 shs$212.74 million05/15/2024$4.94$4.65-5.87%$5.04$4.65458,052 shs$224.32 million05/14/2024$5.14$4.94-3.80%$5.20$4.88437,087 shs$238.31 million05/13/2024$4.81$5.14+6.76%$5.14$4.83321,432 shs$247.71 million05/10/2024$4.79$4.81+0.42%$4.91$4.70232,647 shs$232.03 million05/09/2024$4.83$4.79-0.83%$4.93$4.75268,187 shs$231.07 million05/08/2024$4.75$4.83+1.68%$4.87$4.66261,433 shs$229.14 million05/07/2024$4.62$4.75+2.81%$4.78$4.58338,520 shs$229.14 million05/06/2024$4.86$4.62-4.94%$4.88$4.36583,454 shs$222.87 million05/03/2024$4.96$4.86-2.02%$5.26$4.81390,326 shs$239.11 million05/02/2024$4.95$4.96+0.20%$4.97$4.77319,771 shs$239.12 million05/01/2024$5.07$4.95-2.37%$5.17$4.90256,651 shs$238.64 million04/30/2024$5.02$5.07+1.00%$5.07$4.84230,350 shs$244.43 million04/29/2024$5.02$5.02$5.15$4.95200,357 shs$242.01 million04/26/2024$4.88$5.02+2.87%$5.11$4.87166,206 shs$242.01 million04/25/2024$4.83$4.88+1.04%$5.06$4.72231,234 shs$235.27 million04/24/2024$5.13$4.83-5.85%$5.13$4.77365,894 shs$232.84 million04/23/2024$5.17$5.13-0.77%$5.34$5.10293,866 shs$247.32 million04/22/2024$5.01$5.17+3.19%$5.27$5.00265,408 shs$249.25 million04/19/2024$4.99$5.01+0.40%$5.08$4.90289,863 shs$241.53 million04/18/2024$5.17$4.99-3.48%$5.29$4.93289,054 shs$240.57 million04/17/2024$5.10$5.17+1.37%$5.30$5.05248,185 shs$249.25 million04/16/2024$5.35$5.10-4.67%$5.42$5.06285,862 shs$245.87 million04/15/2024$5.27$5.35+1.52%$5.43$5.25266,546 shs$257.92 million04/12/2024$5.49$5.27-4.01%$5.52$5.21221,459 shs$254.07 million04/11/2024$5.53$5.49-0.63%$5.65$5.46145,675 shs$264.67 million04/10/2024$5.83$5.53-5.23%$5.80$5.40378,661 shs$266.36 million04/09/2024$5.63$5.83+3.55%$6.06$5.59552,098 shs$281.06 million04/08/2024$5.66$5.63-0.53%$5.71$5.44315,158 shs$271.42 millionBill Gates is all about this tiny $2 stock (Ad)What does Bill Gates know about this tiny company that we don’t? From the outside, it looks like a worthless $2 stock…>>Click here to discover why Bill Gates is all about this tiny $2 stock.04/05/2024$5.51$5.66+2.72%$5.84$5.42405,308 shs$272.85 million04/04/2024$5.35$5.51+2.99%$5.57$5.36530,186 shs$265.64 million04/03/2024$5.28$5.35+1.33%$5.35$5.10337,149 shs$257.92 million04/02/2024$5.28$5.28$5.33$5.05375,221 shs$254.55 million04/01/2024$5.30$5.28-0.38%$5.31$5.12400,917 shs$254.55 million03/29/2024$5.30$5.30$5.60$5.24275,380 shs$255.51 million03/28/2024$5.58$5.30-5.02%$5.56$5.24275,380 shs$255.51 million03/27/2024$5.60$5.58-0.36%$5.74$5.38357,775 shs$269.01 million03/26/2024$5.59$5.60+0.18%$5.68$5.37528,484 shs$269.98 million03/25/2024$5.33$5.59+4.88%$5.72$5.25738,070 shs$269.48 million03/22/2024$5.35$5.33-0.37%$5.55$5.16924,198 shs$256.96 million03/21/2024$4.70$5.35+13.95%$5.39$4.621.17 million shs$257.92 million03/20/2024$4.30$4.70+9.19%$4.74$4.24599,143 shs$226.33 million03/19/2024$4.66$4.30-7.73%$4.58$4.151.10 million shs$207.30 million03/18/2024$5.00$4.66-6.80%$5.00$4.481.29 million shs$224.66 million03/15/2024$5.22$5.00-4.21%$5.28$4.96421,906 shs$241.04 million03/14/2024$5.33$5.22-2.06%$5.41$5.10464,922 shs$251.66 million03/13/2024$5.35$5.33-0.37%$5.50$5.26249,017 shs$256.96 million03/12/2024$5.49$5.35-2.55%$5.50$5.24452,996 shs$257.92 million03/11/2024$5.35$5.49+2.62%$5.50$5.27437,382 shs$264.66 million03/08/2024$5.75$5.35-6.96%$5.89$5.32589,741 shs$257.92 million03/07/2024$5.53$5.75+3.98%$5.79$5.42670,026 shs$277.21 million03/06/2024$5.18$5.53+6.76%$5.62$5.00758,905 shs$266.59 million03/05/2024$5.36$5.18-3.36%$5.67$5.18761,036 shs$249.73 million03/04/2024$5.89$5.36-9.00%$5.78$5.15876,995 shs$258.41 million Related Companies: Akebia Therapeutics Stock Chart RAPT Therapeutics Stock Chart Marinus Pharmaceuticals Stock Chart UroGen Pharma Stock Chart Praxis Precision Medicines Stock Chart Nurix Therapeutics Stock Chart Aurinia Pharmaceuticals Stock Chart Wave Life Sciences Stock Chart GH Research Stock Chart Stoke Therapeutics Stock Chart Receive PBYI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Puma Biotechnology and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PBYI) was last updated on 6/3/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBill Gates is all about this tiny $2 stockTimothy SykesBiden Nomination CANCELED?The Freeport SocietyExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsWrite this ticker symbol down…StocksToTradeShocking $16T Elon Musk Crypto LeakCrypto 101 MediaBiden replacement revealed?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Puma Biotechnology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.